Jun 06, 2023 / 08:20PM GMT
Andrew Frederick Brackmann - William Blair & Company L.L.C., Research Division - Research Analyst
Hi, everyone. Good afternoon. For those of you who don't know me, my name is Andrew Brackmann, and I cover diagnostics for William Blair. Thanks for coming to the 43rd Annual Growth Stock Conference. Today, this afternoon, we're pleased to have Quest Diagnostics join us. We have EVP and CFO, Sam Samad. And in the crowd here, we have from Investor Relations VP of IR, Shawn Bevec. Before we get into the formal presentation, I do need to tell you that for a full list of research disclosures and potential conflicts of interest, please see williamblair.com.
And then finally, following this session, we'll be going through the second floor for the breakout session in the Maher room. So I'll turn it over to Sam.
Questions and Answers:
Sam A. Samad - Quest Diagnostics Incorporated - Executive VP & CFOAll right. Thank you, Andrew. All right. Good afternoon, everybody. So I'll be going through some comments and general information session on Quest here